April 26, 2018 6:13 AM ET

Pharmaceuticals

Company Overview of Jaguar Health, Inc.

Company Overview

Jaguar Health, Inc., a commercial stage natural-products pharmaceuticals company, focuses on developing novel, sustainably derived gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Canalevia is the company's lead animal prescription drug product candidate inte...

201 Mission Street

Suite 2375

San Francisco, CA 94105

United States

36 Employees

Phone:

415-371-8300

Key Executives for Jaguar Health, Inc.

CEO, President & Director
Age: 58
Total Annual Compensation: $446.2K
CFO & Treasurer
Age: 61
Total Annual Compensation: $243.4K
Executive VP of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary
Age: 59
Total Annual Compensation: $284.5K
Compensation as of Fiscal Year 2016.

Jaguar Health, Inc. Key Developments

Jaguar Health, Inc. Announces Changes

Jaguar Health, Inc. announced that on March 29, 2018, Dr. Ari Azhir notified the Board of Directors of the company of her intention to resign as a member of the Board, effective upon the close of business on March 29, 2018, including from her role as a member of the Audit Committee and Compensation Committee. Dr. Azhir is resigning to focus on other opportunities and her decision did not involve any disagreement with the company, its management or the Board. Dr. Azhir served as a director of the company since 2016. On March 29, 2018, the Board, by resolution as contemplated in the company's bylaws, appointed Mr. Jonathan B. Siegel, age 44, to fill the vacancy created by Dr. Azhir's resignation and serve as Class I director of the company until the 2019 annual meeting of stockholders or until his successor is elected and qualified. Mr. Siegel is founder of JBS Healthcare Ventures.

Jaguar Health, Inc. announced delayed annual 10-K filing

On 04/02/2018, Jaguar Health, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Jaguar Health, Inc. Appoints Jeffrey C. Johnson as Class III Director and Member of the Compensation Committee

On March 19, 2018, the board of directors of Jaguar Health, Inc., by resolution as contemplated in the company's bylaws, increased the size of the board from seven to nine directors. In connection therewith, and to fill one of the two newly created vacancies, the board appointed Jeffrey C. Johnson to serve as a Class III director of the company until the 2018 annual meeting of stockholders or until his successor is elected and qualified, which appointment became effective as of the consummation of the Preferred Stock Offering. Mr. Johnson was also appointed by the board to serve as a member of its Compensation Committee. Mr. Johnson is a partner at Sagard Holdings, ULC and an investment manager at SCPM. He previously served as portfolio manager and senior analyst at Evercore Asset Management. He also serves on the board of directors of Peak Achievement Athletics and previously served on the board of directors of Vein Clinics of America.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 26, 2018
--
Private Placement
March 23, 2018
--
Private Placement
March 21, 2018
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Jaguar Health, Inc., please visit jaguar.health. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.